Sector: Technology | Industry: Software |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 |
Tel: | 1-855-3096800 |
Website: | https://www.healthcatalyst.com |
IR: | See website |
Key People | ||
Daniel D. Burton Chief Executive Officer, Director | Jason Alger Chief Financial Officer, Chief Accounting Officer | Daniel Lesueur Chief Operating Officer |
Linda Llewelyn Chief People Officer | Benjamin Landry General Counsel, Corporate Secretary | Anne Marie Bickmore Chief Product Officer | Kevin Freeman Chief Commercial Officer |
Business Overview |
Health Catalyst, Inc. is a provider of data and analytics technology and services to healthcare organizations. The Company's solution comprises its cloud-based data and analytics platform, software applications, and professional services expertise. The Company operates through two segments: Technology and Professional Services. The Technology segment includes its data platform, analytics applications and support services and is focused primarily on contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees. The Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver capabilities to its customers to fully configure and utilize the benefits of its technology offerings. Its clients include academic medical centers, integrated delivery networks, community hospitals, physician practices, health insurers, and others. |
Financial Overview |
For the three months ended 31 March 2024, Health Catalyst Inc revenues increased 1% to $74.7M. Net loss decreased 38% to $20.6M. Revenues reflect Professional Services segment increase of 4% to $27.8M. Lower net loss reflects Litigation costs decrease from $11.7M (expense) to $0K, Research and development - Balancing val decrease of 27% to $10.2M (expense). Basic Earnings per Share excluding Extraordinary Items increased from -$0.60 to -$0.35. |
Employees: | 728 as of Mar 31, 2019 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $308.85M as of Mar 31, 2024 |
Annual revenue (TTM): | $296.79M as of Mar 31, 2024 |
EBITDA (TTM): | -$42.43M as of Mar 31, 2024 |
Net annual income (TTM): | -$105.54M as of Mar 31, 2024 |
Free cash flow (TTM): | -$30.98M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 59,034,936 as of May 6, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |